Pere Barba

Bellaterra, CT, ES

Expertise in

conditions

Bellaterra, CT, ES

OverviewLocationsClinical Research

Overview

Pere Barba practices in Bellaterra, Spain. Barba is highly rated in 14 conditions, according to our data. Their top areas of expertise are Acute Lymphoblastic Leukemia (ALL), B-Cell Lymphoma, Leukemia, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 143 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Bellaterra, CT, Spain

Other Locations

Barcelona, CT, Spain

Madrid, MD 28040, Spain

Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Enrollment Status: Active_not_recruiting

Publish Date: October 31, 2024

Intervention Type: Drug

Study Drugs: Ponatinib, Imatinib, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone

Study Phase: Phase 3

A Prospective Multicenter Open-label, Not Controlled Phase Ib-II Clinical Trial to Assess the Safety and Immunologic Efficacy of Virus-specific T Lymphocytes From the Best Donor in Receptors of Hematopoietic Progenitor Allogeneic Transplant

Enrollment Status: Completed

Publish Date: January 24, 2024

Intervention Type: Drug

Study Drug: Activated T-lymphocytes

Study Phase: Phase 1/Phase 2

View 1 Less Clinical Trial

143 Total Publications

Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma.

Journal: JAMA network open

Published: February 25, 2025

View All 143 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Barba's expertise for a condition

ConditionClose